ENDONOVO THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2011 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Endonovo Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2011 to Q3 2023.
  • Endonovo Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2023 was 319M shares, a 100% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 319M +160M +100% Sep 30, 2023 10-Q/A 2023-12-29
Q2 2023 279M +128M +85.3% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 270M +189M +232% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 213M +139M +186% Dec 31, 2022 10-Q/A 2023-12-29
Q3 2022 159M +90M +130% Sep 30, 2022 10-Q 2022-11-21
Q2 2022 150M +89.8M +148% Jun 30, 2022 10-Q 2022-08-22
Q1 2022 81.3M +29.8M +57.8% Mar 31, 2022 10-Q 2022-05-19
Q4 2021 74.5M +50M +204% Dec 31, 2021 10-K 2023-04-17
Q3 2021 69.2M +51.9M +300% Sep 30, 2021 10-Q 2021-11-19
Q2 2021 60.7M +53.4M +741% Jun 30, 2021 10-Q 2021-08-23
Q1 2021 51.5M +44.3M +614% Mar 31, 2021 10-Q 2021-05-24
Q4 2020 24.5M +23.3M +1963% Dec 31, 2020 10-K 2022-04-14
Q3 2020 17.3M -817M -97.9% Sep 30, 2020 10-Q 2020-11-19
Q2 2020 7.21M -723M -99% Jun 30, 2020 10-Q 2020-08-19
Q1 2020 7.21M -510M -98.6% Mar 31, 2020 10-Q 2020-06-12
Q4 2019 1.19M +758K +176% Dec 31, 2019 10-K 2021-04-13
Q3 2019 834M +453M +119% Sep 30, 2019 10-Q 2019-11-19
Q2 2019 731M +374M +105% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 517M +179M +52.9% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 431K -317M -99.9% Dec 31, 2018 10-K 2020-05-04
Q3 2018 381M +97.3M +34.3% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 356M +112M +45.9% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 338M +112M +49.8% Mar 31, 2018 10-Q 2018-05-18
Q4 2017 317M +183M +136% Dec 31, 2017 10-K 2019-04-15
Q3 2017 284M +159M +128% Sep 30, 2017 10-Q/A 2017-11-09
Q2 2017 244M +126M +107% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 226M +117M +108% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 134M +29.5M +28.2% Dec 31, 2016 10-K 2018-04-06
Q3 2016 125M +22.8M +22.4% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 118M Jun 30, 2016 10-Q 2016-08-12
Q1 2016 108M +11.9M +12.3% Mar 31, 2016 10-Q/A 2016-05-27
Q4 2015 105M +23.4M +28.7% Dec 31, 2015 10-K 2017-04-17
Q3 2015 102M Sep 30, 2015 10-Q 2015-11-23
Q1 2015 96.4M Mar 31, 2015 10-Q/A 2015-06-15
Q4 2014 81.4M +80.6M +9684% Dec 31, 2014 10-K/A 2016-05-17
Q4 2013 832K -52.9M -98.5% Dec 31, 2013 10-K/A 2015-06-15
Q3 2013 75.8M Sep 30, 2013 10-Q 2013-12-18
Q2 2013 61.2M Jun 30, 2013 10-Q/A 2013-08-28
Q1 2013 61.2M Mar 31, 2013 10-Q/A 2013-06-21
Q4 2012 53.7M +15.4M +40.1% Dec 31, 2012 10-Q 2013-12-18
Q4 2011 38.3M Dec 31, 2011 10-K/A 2013-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.